Mark Casale

CEO Mark Casale sells 102,599 shares at blended avg $65.19 for $6.7M under 10b5-1 plan

Mark Casale, Chairman, CEO and President, executed 2 separate sales totaling 102,599 shares for $6,688,708.77 on July 13-14, 2026, reducing his holdings from 2,184,143 shares to 2,081,544 shares (a -4.7% reduction). This transaction is part of a pre-arranged 10b5-1 trading plan, meaning it is scheduled and not discretionary. His prior trades at ESNT show a 30-day return of -10.3% on the April 28 sale, though two more recent ESNT sales on July 6-7 do not yet have measurable outcomes. The stock currently trades at $63.60, below the blended sale price of $65.19 but within its 52-week range of $55.22–$67.09; the 30-day price trend has been positive at +9.3%.

Mark Casale sells 30,574 shares for $1,997,674.75 via scheduled 10b5-1 plan at ESNT

Mark Casale, Chairman, CEO and President, executed 2 separate sales totaling 30,574 shares for $1,997,674.75 under a pre-arranged 10b5-1 trading plan, reducing his holdings from 2,214,717 shares to 2,184,143 shares. Because this is a scheduled transaction under a 10b5-1 plan, it reflects a predetermined execution rather than a discretionary market decision. His prior sale at ESNT on 2026-04-28 saw a 30-day return of -10.3%, though no comparable outcome window exists yet for the current filing. The stock has risen 12.8% over the past 30 days and trades at $64.11, approximately 4.4% below its 52-week high of $67.09, providing context on the equity's current valuation relative to recent range.

ESNT CEO Mark Casale sells ~13k shares for ~$850k as stock recovers from recent pullback

Mark Casale, the Chairman, CEO, and President of Essent Group, sold roughly 13,000 shares in a transaction totaling approximately $850,000. The timing is notable: the stock had recently surged and was trading just below its recent highs when Casale executed the sale. While this is a meaningful dollar amount, it represents less than 1% of his total holdings, suggesting a partial diversification rather than a conviction-driven exit. Essent is a solidly profitable company with healthy earnings and a reasonable valuation, so this sale carries no red flags about fundamental deterioration. Executive sales of this magnitude are routine portfolio management—likely driven by personal liquidity needs or systematic rebalancing rather than insider concern about the company's prospects.